
## **Trustees' Annual Report for the period** 

Period start date Period end date 01 August 2024 31 July 2025 **From To** 

## Section A                        Reference and administration details 

|**Charity name**<br>**Other names charity is known by**<br>**Registered charity number (if any)**<br>**Charity's principal address**|Bonded Thru Cancer|Bonded Thru Cancer|
|---|---|---|
||||
||||
||1183619<br> <br>The Trampery<br>ANCHORAGE HOUSE, 2 CLOVE CRESCENT<br>LONDON<br>**Postcode**<br>E14 2BE||
|||E14 2BE|



## **Names of the charity trustees who manage the charity** 

|1<br>2<br>3<br>4<br>5<br>6<br>7<br>8<br>9<br>10<br>11<br>12<br>13<br>14<br>15<br>16<br>17<br>18<br>19<br>20|**Trustee name**|**Office (if any)**|**Dates acted if not for whole**<br>**year**|**Name of person (or body) entitled**<br>**to appoint trustee(if any)**|
|---|---|---|---|---|
||Natasha<br>Veerasawmy|Chair|||
||Freda Peeches<br>Maledon Ochoa||||
||Paulina Balogun||||
||Pamela Hammond||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||



**Names of the trustees for the charity, if any, (for example, any custodian trustees)** 

**Name Dates acted if not for whole year** 

March **2012** 

**TAR** 

1 



## **Names and addresses of advisers (Optional information)** 

**Type of adviser Name Address** 

## **Name of chief executive or names of senior staff members (Optional information)** 

## **Section B              Structure, governance and management** 

## **Description of the charity’s trusts** 

Type of governing document 

Constitution 

- (eg. trust deed, constitution) 

Company How the charity is constituted 

- (eg. trust, association, company) 

Appointed by the Chair and at least one trustee Trustee selection methods 

- (eg. appointed by, elected by) 

## **Additional governance issues (Optional information)** 

You **may choose** to include additional information, where relevant, about: 

- policies and procedures adopted for the induction and training of trustees; 

- the charity’s organisational structure and any wider network with which the charity works; 

- relationship with any related parties; 

- trustees’ consideration of major risks and the system and procedures to manage them. 

## **Section C                    Objectives and activities** 

To support the health and well-being of cancer patients and their loved ones in England and Wales by: 

**Summary of the objects of the charity set out in its governing document** 

a) Raising awareness among the public and medical professionals about the emotional and well-being needs of cancer patients and their families. b) Providing friendship and support to cancer patients during and after treatment. 

March **2012** 

**TAR** 

2 



**Summary of the main activities undertaken for the public benefit in relation to these objects (include within this section the statutory declaration that trustees have had regard to the guidance issued by the Charity Commission on public benefit)** 

**Additional details of objectives and activities (Optional information)** 

You **may choose** to include further statements, where relevant, about: 

- policy on grantmaking; 

- policy programme related investment; 

- contribution made by volunteers. 

March **2012** 

**TAR** 

3 



## Section D                      Achievements and performance 

**Summary of the main achievements of the charity during the year** 

Bonded Thru Cancer’s (BTC) primary focus is to preserve and protect the health and wellbeing of cancer patients and their loved ones in London and surrounding areas. This is achieved by raising awareness among the public and medical professionals about the emotional and wellbeing needs of individuals diagnosed with cancer and their families. BTC also provides direct support by befriending cancer patients and offering assistance during and after their medical treatment. 

Trustees of Bonded Thru Cancer have actively volunteered as buddies to cancer patients, providing vital support by accompanying them to medical appointments and offering a safe space for counsel and emotional comfort. These efforts ensure that beneficiaries receive both practical and emotional care during one of the most challenging periods of their lives. 

In carrying out these activities, the trustees have had full regard to the guidance issued by the Charity Commission on public benefit, ensuring that all actions align with Bonded Thru Cancer’s objectives and deliver meaningful support to the community. 

March **2012** 

**TAR** 

4 



## **Section E                    Financial review** 

**Brief statement of the** 

**charity’s policy on reserves** 

Bonded Thru Cancer is a small charity dedicated to ensuring that all funds raised are directed back into our primary activities of supporting cancer patients and their loved ones. As such, we do not currently hold significant reserves. Any donations or income received are promptly allocated to delivering our services, including raising awareness, providing emotional support, and offering practical assistance to those in need. This approach ensures that every contribution directly benefits our beneficiaries and aligns with our mission to make a meaningful impact in their lives. 

**Details of any funds materially in deficit** 

## **Further financial review details (Optional information)** 

You **may choose** to include additional information, where relevant about: 

- the charity’s principal sources of funds (including any fundraising); 

- how expenditure has supported the key objectives of the charity; 

- investment policy and objectives including any ethical investment policy adopted. 

## **Section F                     Other optional information** 

## **Section G                    Declaration** 

**The trustees declare that they have approved the trustees’ report above.** 

**Signed on behalf of the charity’s trustees** 

**Signature(s)** P Balogun **Full name(s)** Paulina Balogun **Position (eg Secretary, Chair,** Trustee **etc)** 

March **2012** 

**TAR** 

5 



Date
2510512026
TAR
Maich 2012


**Bonded Thru Cancer 1183619 Receipts and payments accounts CC16a For the period** Period start date Period end date **To from** 8/1/2024 31-Jul-25 

## **Section A Receipts and payments** 

|**A1 Receipts**|**Unrestricted**<br>**funds**<br>**to the nearest**<br>**£**<br>**1,000**<br>**852**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**1,852**<br>**-**<br>**-**<br>**-**<br>**1,852**<br>**4,910**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br> **4,910**<br>**-**<br>**-**<br> **-**<br>**4,910**<br>**-                 3,058**<br>**-**<br>**-**<br>**-                 3,058**|**Restricted**<br>**funds**<br>**to the nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**|**Endowment**<br>**funds**<br>**to the nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**|**Total funds**<br>**to the nearest £**<br>**1,000**<br>**852**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**1,852**<br>**-**<br>**-**<br>**-**<br>**1,852**<br>**4,910**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**4,910**<br>**-**<br>**-**<br>**-**<br>**4,910**<br>**-                 3,058**|**Total funds**<br>**to the nearest £**<br>**1,000**<br>**852**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**1,852**<br>**-**<br>**-**<br>**-**<br>**1,852**<br>**4,910**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**4,910**<br>**-**<br>**-**<br>**-**<br>**4,910**<br>**-                 3,058**|**Last year**<br>**to the nearest £**|
|---|---|---|---|---|---|---|
||**1,000**|||||**-**|
||**852**|||||**-**|
||**-**|||||**-**|
||**-**|||||**-**|
||**-**|||||**-**|
||**-**|||||**-**|
||**-**|||||**-**|
||**-**|||||**-**|
|**_Sub total_**_(Gross income for_<br>_AR)_|**1,852**|||||**-**|
||||||||
|**A2 Asset and investment sales,**<br>**(see table).**|||||||
||**-**||||||
||**-**|||||**-**|
|**_Sub total_**|**-**|||||**-**|
|**_Total receipts_**<br>**A3 Payments**|||||||
|||||||**-**|
||||||||
||**4,910**|||||**-**|
||**-**|||||**-**|
||**-**|||||**-**|
||**-**|||||**-**|
||**-**|||||**-**|
||**-**|||||**-**|
||**-**|||||**-**|
||**-**|||||**-**|
||**-**|||||**-**|
|**_Sub total_ **|**4,910**|||||**-**|
||||||||
|**A4 Asset and investment**<br>**purchases, (see table)**|||||||
||**-**||||||
||**-**||||||
|**_Sub total_ **|**-**|||||**-**|
|**_Total payments_**<br>**_Net of receipts/(payments)_**<br>**A5 Transfers between funds**<br>**A6 Cash funds last year end**<br>**_Cash funds this year end_**|||||||
|||||||**-**|
||||||||
||**-                 3,058**|**-**|**-**|**-                 3,058**||**-**|
||**-**|**-**|**-**|**-**||**-**|
||**-**|**-**|**-**|**-**||**-**|
||**-                 3,058**|**-**|**-**|**-                 3,058**||**-**|



CCXX R1 accounts (SS) 

1 



## **Section B Statement of assets and liabilities at the end of the period** 

|**Categories**<br>Signed by one or two trustees on<br>behalf of all the trustees<br>**B1 Cash funds**<br>**B2 Other monetary assets**<br>**B4 Assets retained for the**<br>**charity’s own use**<br>**B5 Liabilities**<br>**B3 Investment assets**|Signature<br>**Details**<br>**Details**<br>**_Total cash funds_**<br>(agree balances with receipts and payments<br>account(s))<br>**Details**<br>**Details**<br>**Details**|**Unrestricted**<br>**funds**<br>**Restricted**<br>**funds**<br>**to nearest £**<br>**to nearest £**<br>**-                     3,058**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-                 3,058**<br>**-**<br>OK<br>OK<br>**Unrestricted**<br>**funds**<br>**Restricted**<br>**funds**<br>**to nearest £**<br>**to nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Fund to which**<br>**asset belongs**<br>**Cost (optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Fund to which**<br>**asset belongs**<br>**Cost (optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Fund to which**<br>**liability relates**<br>**Amount due**<br>**(optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>Print Name|**Endowment**<br>**funds**<br>**to nearest £**|
|---|---|---|---|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||OK|
||||**Endowment**<br>**funds**<br>**to nearest £**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**Current value**<br>**(optional)**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**Current value**<br>**(optional)**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**When due**<br>**(optional)**|
|||||
|||||
|||||
|||||
|||||
|||||
||||Date of<br>approval|
|||||
|||||



CCXX R2 accounts (SS) 

2 

